Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 117,641 | 87,880 | 67,281 | 55,144 | 58,042 |
| Marketable Securities | 258,162 | 205,047 | 253,040 | 202,962 | 155,027 |
| Receivables | 71,187 | 77,190 | 71,478 | 69,021 | 57,315 |
| Other current assets | 60,384 | 58,610 | 24,985 | 26,444 | 56,155 |
| TOTAL | $507,374 | $428,727 | $416,784 | $353,571 | $326,539 |
| Non-Current Assets | |||||
| PPE Net | 111,865 | 110,223 | 107,077 | 105,549 | 106,810 |
| Investments And Advances | 411,778 | 484,471 | 494,111 | 570,351 | 602,232 |
| Intangibles | 160,335 | 153,115 | 155,064 | 157,033 | 159,170 |
| Other Non-Current Assets | 23,211 | 23,302 | 32,708 | 33,460 | 39,012 |
| TOTAL | $707,189 | $771,111 | $788,960 | $866,393 | $907,224 |
| Total Assets | $1,214,563 | $1,199,838 | $1,205,744 | $1,219,964 | $1,233,763 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,088 | 18,887 | 18,238 | 18,364 | 19,805 |
| Accrued Expenses | 23,010 | 21,699 | 16,689 | 24,279 | 23,862 |
| Other current liabilities | 30,852 | 30,273 | 30,512 | 29,844 | 29,911 |
| TOTAL | $72,426 | $71,335 | $65,915 | $72,899 | $73,990 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 14,558 | 11,042 | 11,191 | 11,838 | 18,187 |
| TOTAL | $21,380 | $16,867 | $17,059 | $17,906 | $24,875 |
| Total Liabilities | $93,806 | $88,202 | $82,974 | $90,805 | $98,865 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,912 | 30,609 | 30,444 | 30,829 | 30,587 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 553,372 | 559,980 | 578,937 | 590,467 | 596,355 |
| Other shareholders' equity | 1,692 | 1,054 | -73 | -4,437 | 5,631 |
| TOTAL | $1,120,757 | $1,111,636 | $1,122,770 | $1,129,159 | $1,134,898 |
| Total Liabilities And Equity | $1,214,563 | $1,199,838 | $1,205,744 | $1,219,964 | $1,233,763 |